Commentary on 'Forum: Use of antidepressants in children and adolescents'

Current Opinion in Psychiatry

Volumn 23, Issue 1, 2010, Pages 65-66

  Herpertz Dahlmann, Beate ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

CHILD CARE; COGNITIVE THERAPY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; NOTE; PLACEBO EFFECT; PREVALENCE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SUICIDE;

ADOLESCENT; BEHAVIOR THERAPY; CHILD; DEPRESSIVE DISORDER; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 74349116762     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000365438.82265.b3     Document Type: Note

References (8)

1. Brent DA, Weersing VR. Depressive disorders. In: Martin A, Volkmar FR, editors. Lewis's child and adolescent psychiatry. A comprehensive textbook, 4th ed. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2007. pp. 503-512.
2. Vitiello B. An update on publicly funded multisite trials in pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am 2006; 15:1-12.
3. Kennard BD, Silva SG, Tonev S, et al. Remission and recovery in the treatment for adolescents with depression study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009; 48:186-195.
4. Byford S, Barrett B, Roberts C, et al. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. Br J Psychiatry 2007; 191:521-527. (Pubitemid 350273213)
5. Brent DA, Emslie GJ, Clarke GN, et al. Switching to venlafaxine or another SSRI with or without cognitive behavioral therapy for adolescents with SSRIresistant depression: the TORDIA randomized control trial. JAMA 2008; 299:901-913.
6. Vitiello B. Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: does it improve outcomes compared with monotherapy? CNS Drugs 2009; 23:271-280.
7. Kennard BD, Silva SG, Mayes TL, et al. Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. Am J Psychiatry 2009; 166:337-344.
8. Bridge JA, Birmaher B, Iyengar S. Placebo response in randomized controlled trials of antidepressants for pediatrc major depressive disorder. Am J Psychiatry 2009; 166:42-49.